According to CNBC, Novo Nordisk (NVO), Huntington Ingalls Industries (HII), and ZIM Integrated Shipping Services (ZIM) were identified as among the biggest U.S. premarket movers ahead of the Dec 23, 2025 open, source: CNBC. Traders can reference CNBC’s premarket list to confirm any company-specific headlines and premarket price changes on these tickers before planning entries, stops, and sizing into the opening bell, source: CNBC. CNBC did not cite any direct impact on crypto assets such as BTC or ETH in this premarket note, source: CNBC.

According to @business, Novo Nordisk's Mike Doustdar lost a $10 billion takeover battle for obesity drug developer Metsera to Pfizer (PFE) (source: @business). According to @business, he is keeping deals on the table as the Danish company seeks to regain lost ground in the weight-loss boom (source: @business). According to @business, the report makes no mention of cryptocurrencies or digital assets and states no direct crypto-market linkage (source: @business).

According to @FoxNews, Pfizer has secured a $10 billion deal to acquire Metsera, ending a bidding war with Novo Nordisk and giving Pfizer a new foothold in the obesity-drug market, a headline relevant for traders focused on large-cap pharma and weight-loss treatment exposure (source: Fox News tweet; Fox Business report). The report did not cite any direct impact on cryptocurrency markets (source: Fox News tweet; Fox Business report).